More Industry News & Trends

More News

Monthly Orthopedic Deals Topped by $5.4B Acquisition

Three notable orthopedic deals took place between Oct. 15 and Nov. 15, the largest being the acquisition of Wright Medical by Stryker. The $5.4 billion deal is expected to close in the second half ...

AAHKS Meeting Draws Over 4 Thousand to Dallas

More than 4 thousand doctors attended the sixth annual meeting of the American Association of Hip and Knee Surgeons from Nov. 7-10 at the Hilton Anatole in Dallas, Texas. AAHKS President Michael P ...

Neuromodulation Revenue Clouds Otherwise Healthy Third Quarter

Orthopedic industry revenue increased 4.5 percent in Q3-2019 when compared with Q3-2018. All segments exhibited single-digit growth except neuromodulation. Compared with the same quarter last year,...

Glaukos Completes Acquisition of Corneal Cross-Linking Developer Avedro

Glaukos, maker of the iStent inject, announced Nov. 21 that it has completed its previously announced acquisition of Avedro, developer of corneal cross-linking. Thomas Burns, Glaukos president and ...

Roche Again Extends Tender Offer for Shares in its Bid to Acquire Spark

Roche once again delayed its tender offer for the $4.3 billion acquisition of Spark Therapeutics. “[T]o provide additional time for the US Federal Trade Commission (FTC) and the UK Competition and ...

Study Finds Increase in Pediatric Eye Injuries from Nonpowder Firearms

Eye injuries from nonpowder firearm incidents are on the rise in the United States, according to a new study by researchers at the Center for Injury Research and Policy at Nationwide Children’s Hos...

Biogen Completes Enrollment in Global Phase III Gene Therapy Study for Choroideremia

Biogen, of Cambridge, Massachusetts, announced Nov. 21 that it had enrolled the last patient in its global Phase III STAR clinical study, evaluating the investigational gene therapy timrepigene emp...

Nidek Launches YC-200 and YC-200 S Plus Lasers in the US

Nidek announced Nov. 18 that the US FDA had issued 510(k) clearance for the YC-200 ophthalmic YAG laser system. The YC-200 also comes in the S plus model for selective laser trabeculoplasty (SLT). ...

LightMed Introduces New Design of its Flexible Pattern-Scanning Laser

LightMed, of San Clemente, California, announced the launch on Nov. 18 of its LIGHTLas TruScan Pro V2.0, an advanced and flexible pattern-scanning laser that can be configured with up to four diffe...

Nuvectra Files Bankruptcy

Nuvectra announced Nov. 14 that it filed for reorganization under Chapter 11 of the US Bankruptcy Code. It also filed for consensual collateral support and employee wage and benefit support from th...

Ophthalmic Laser Market Expected to Total $406 Million in 2019

Global revenue for ophthalmic lasers—photocoagulation, photodisruption (YAG), and SLT—along with maintenance, accessories, and endoprobes, will total nearly $406 million in 2019 and grow at a compo...

Positive US Payer Decisions Expected to Drive Artificial Disc Replacement Market

Currently, 11 artificial disc replacement (ADR) devices are approved by the FDA. The first ADRs were for lumbar cases. However, insurance companies in the US stopped covering the procedure in 2013 ...

2019 AAO: Delivery Techniques for Gene, Cell Therapy Take Center Stage at Retina Subspecialty Day

The American Academy of Ophthalmology’s Retina Subspecialty Day cast a big net with its 2019 agenda, covering surgical and medical retina and diagnostics. The two-day program preceded the AAO’s ann...

2019 AAO: Cornea Sessions Focus on Keratoconus, Ectasia

Keratoconus and ectasia were frequent topics in conference sessions and during the Refractive and Cornea Subspecialty Days at the 2019 AAO meeting. Physicians were eager to gain a better understand...

Ophthalmic Deals Surge in 2018-2019; Most Transactions Involve New Ventures

Ophthalmic deals garnered over $9 billion from January 2018 through October 2019, driven largely by dry eye and retina related fundraising. Over 100 transactions occurred during this period, and ov...

Aurinia Applies Pressure in Race for Next Dry Eye Pharmaceutical Drug

Aurinia Pharmaceuticals’ initiation of its Phase II/III AUDREY trial in dry eye keeps Aurinia in the middle of the pack of companies racing to develop the next pharmaceutical treatment for dry eye ...

Alcon Reports Q3-2019 Sales of $1.84 Billion, a 4 Percent Increase

Alcon reported Nov. 19 that its Q3-2019 sales totaled $1.84 billion, an increase of 4 percent (+6 percent cc) over $1.76 billion in Q3-2018. The Switzerland-registered, Texas-based company raised i...

FDA Approves First Contact Lens Indicated to Slow Progression of Myopia in Children

The US Food and Drug Administration (FDA) approved on Nov. 15 the first contact lens indicated to slow the progression of myopia (nearsightedness) in children between the ages of 8 and 12 at the in...

Aerie Receives European Commission Approval for Rhokiinsa

Aerie Pharmaceuticals announced Nov. 21 that the European Commission (EC) had granted marketing authorization for Rhokiinsa—known as Rhopressa in the US—for the reduction of elevated intraocular pr...

FDA Accepts Samsung Bioepis’ BLA for SB8 Bevacizumab Biosimilar Candidate

The US Food and Drug Administration (FDA) has accepted for review Samsung Bioepis’ biologics license application (BLA) for SB8, a biosimilar candidate referencing Genentech’s Avastin (bevacizumab),...

IDx-DR Autonomous AI Diagnostic System Launches in Retail Health Clinics

Patients at CarePortMD retail health clinics at Albertsons grocery stores now have access to a diabetic retinopathy eye exam performed with the FDA-cleared autonomous AI diagnostic system IDx-DR. A...

Baring Private Equity Asia Agrees to Acquire Lumenis, Values Laser Company at over $1 Billion

Hong Kong’s Baring Private Equity Asia announced Nov. 19 that its affiliated funds have agreed to acquire Israel-based Lumenis, maker of ophthalmic lasers and other energy-based medical devices, fr...

Nicox Raises $13.9 Million to Advance NCX 470 into Phase III in Glaucoma

French company Nicox has issued3,315,650 new ordinary shares through a private placement, with gross proceeds of $13.9 million, the company announced Nov. 18. Proceeds from the financing will suppo...

NovaBay Now Selling NovaSight Daily Vitamin for Ocular Health on Amazon.com

NovaBay Pharmaceuticals announced Nov. 18 that it had launched NovaSight, a proprietary daily vitamin and mineral supplement specially formulated to support ocular health, on Amazon.com. NovaSight ...

Data on Optometrist Salaries, Student Loan Debt Analyzed in 2019 Career Report

Career development company CovalentCareers has released its 2019 Optometrist Report, based on data collected from 1,181 optometrists, optometry students, and practice owners. The report details opt...

Aerie Set to Acquire Avizorex to Advance Its Dry Eye Program

Aerie Pharmaceuticals, of Durham, North Carolina, has signed an agreement for the acquisition of Avizorex Pharma (AVX), a Spanish company developing therapeutics for the treatment of dry eye diseas...

Regenxbio Sues FDA over Unexplained Clinical Holds Placed on Trials

Gene therapy company Regenxbio has filed a lawsuit against the US FDA and Health Secretary Alex Azar II over FDA regulators placing clinical holds on two of the company’s clinical trials for RGX-31...

Bausch Health Licenses Clearside’s Xipere for Macular Edema with Uveitis

Bausch Health and Clearside Biomedical have agreed on a deal to develop and commercialize Clearside’s Xipere (triamcinolone acetonide suprachoroidal injectable suspension) in the US and Canada, the...

2019 AAO: Sessions Showcase New and Next-Generation IOLs

Alcon’s PanOptix trifocal lens garnered much of the attention at refractive- and cataract-focused sessions and on the exhibit floor at the 2019 meeting of the American Academy of Ophthalmology, hel...

2019 AAO: Doctors, Private Equity Firms Discuss Range of Factors Involved in Consolidation

Private equity was a common theme at the 2019 AAO meeting, and discussions often centered on the increasing consolidation within ophthalmology. Sessions focused on educating ophthalmologists and pr...

2019 AAO: Floaters Symposium Evaluates the Latest Developments in Treatment

Ellex and the International Ophthalmic Floater Society (IOFS) sponsored a symposium on advancements in technology that have improved the opportunities for floater treatment. The event was held in c...

2019 AAO: Surgeons Debate Value of 3D Displays at Retina Subspecialty Day

A debate on 3D heads-up displays stood out during the Retina Subspecialty Day because the discussion differed greatly from the terms used to market the devices just three years ago. Jennifer Lim, M...

OIS Draws More Than 1,150 for Summit Ahead of AAO Meeting

A record crowd attended the 2019 Ophthalmology Innovation Summit in advance of the AAO meeting. The meeting was held Oct. 10 at the Hilton San Francisco Union Square. Forty-one percent of the 1,150...

Amarantus Licenses MANF Retinal Candidate, Other Assets to Emerald Organic Growth

Amarantus Bioscience announced Oct. 24 that it agreed to license its therapeutic assets to Emerald Organic Growth, a cannabinoid-based health sciences company located in Holbrook, New York. It is u...

Oyster Point Pharma Leads Latest Fundraising Efforts with $92 Million IPO

Oyster Point Pharma led recent fundraising efforts by ophthalmic companies, raising $92 million in gross proceeds in its initial public offering. Other firms with financing deals included Nicox, ra...

J&J Vision Shuts Down Sightbox Contact Lens Service Acquired in 2017

Johnson & Johnson Vision (J&J Vision) announced Oct. 28 that it will cease customer-facing operations for Sightbox, its online contact lens subscription service, while it evaluates options for the ...

Ophthalmic Laser Market Expected to Total $406 Million in 2019

Spencer Thornton, MD, Dies at Age 90

Spencer P. Thornton, MD, FACS, a renowned ophthalmologist and former president of the American Society of Cataract and Refractive Surgery (ASCRS), died Oct. 26 at the age of 90. Colleagues remember...

Market Scope Weekly Ophthalmic Surgeon Poll for November 2019

November 2019 Ophthalmic News Briefs

Coherus BioSciences will market and distribute Bioeq AG’s ranibizumab biosimilar candidate in the US under a licensing agreement announced Nov. 6. Bioeq, of Switzerland, will retain responsibility ...

Medacta and Geisinger Extend Lifetime Guarantee to Knee Revisions

Medacta and Geisinger announced in 2018 that they were launching a pilot program for lifetime-guaranteed hip replacements; the companies added knee replacements to the program in March 2019. On Nov...

Bioness PNS Achieves Positive Results for Focal Mononeuropathy Treatment

Bioness, a California-based provider of the StimRouter Peripheral Nerve System (PNS), announced Nov. 14 that positive clinical trial results for the device were published in the November issue of P...

CMS Increases SI Joint Arthrodesis Physician Payment by 27 Percent

Announced Nov. 5, the US Centers for Medicare and Medicaid Services increased the Medicare physician payment for sacroiliac (SI) joint arthrodesis. Starting Jan. 1, the relative value units for the...

Spineology Fusion Trial Achieves Positive 24-Month Results

Spineology announced Nov. 4 that 24-month outcomes for its SCOUT clinical trial are positive. The trial is prospective, multi-center, and non-randomized, and it follows IDE protocol. One hundred an...

Regenxbio Sues FDA over Unexplained Clinical Holds Placed on Two Trials for Retinal Candidates

Omeros Reports Q3-2019 Revenue of $29.9 Million for Omidria

Omeros reported Nov. 12 that its Q3-2019 revenue was $29.9 million, a 12 percent increase over the previous quarter in 2019. Omidria is the company’s sole product for sale. Omeros has seen strong d...

NuEyes Technologies Granted Patent for its Augmented Reality Technology for Low Vision

NuEyes, of Newport Beach, California, announced Nov. 12 that the US Patent and Trademark Office had issued the company US Patent 10,429,675 for a “System for Using Augmented Reality for Vision.” Th...

Iridex Reports Q3-2019 Revenue of $10.7 Million, a Decrease of 5.8 Percent

Iridex reported Nov. 7 that Q3-2019 revenue totaled $10.7 million, a decrease of 5.8 percent from $11.3 million in the same period of 2018. Revenue from retinal products was $5.8 million, a decreas...

Harrow Health Reports Q3-2019 Revenue of $12.8 Million, a 19 Percent Increase

Harrow Health reported Nov. 13 that Q3-2019 revenue totaled $12.8 million, a 19 percent increase over Q3-2018 revenue of $10.7 million. Harrow, founded in 2014 and now located in Nashville, Tenness...

Coherus Licenses Bioeq's Lucentis Biosimilar Candidate for US

Coherus BioSciences will market and distribute Bioeq AG's Lucentis biosimilar candidate in the US under a licensing agreement announced Nov. 6. Bioeq, of Switzerland, will retain responsibility...

Bausch + Lomb Records Q3-2019 Revenue of $1.18 Billion, a 2 Percent Increase

Bausch Health announced Nov. 4 that its Bausch + Lomb/International segment posted Q3-2019 revenue of $1.18 billion, a 2 percent increase (4 percent cc) over Q3-2018 revenue of $1.15 billion. The i...

Alimera Sciences Terminates New Equity Purchase Agreement

Alimera Sciences has terminated its $20 million common stock purchase agreement with Lincoln Park Capital Fund, the company announced Nov. 12. Rick Eiswirth, president and CEO of Alimera, said: “Ha...

HSS Uses 3dMD and EOS Technology to Treat Scoliosis Patients

The Hospital for Special Surgery (HSS) announced Nov. 7 that it is enrolling patients in a study that uses 3dMD technology and EOS imaging to treat scoliosis patients. 3dMD’s imaging system reduces...

FDA Approves IND Application for Flexion’s Gene Therapy OA Treatment

Flexion Therapeutics said Oct. 31 that the FDA has approved its Investigational New Drug (IND) application for gene therapy treatment FX201. The therapy is a non-integrating adenovirus containing t...

WishBone and Optimal Sign Global Distribution Agreement

WishBone Medical announced Oct. 29 that it signed a global distribution agreement with Optimal for its pediatric orthopedic implant systems. Optimal is an automated logistics inventory service comp...

Life Spine Settles FCA Lawsuit for $6M

Life Spine settled the civil health care fraud lawsuit filed against it under the False Claims Act for $6 million, the company announced Oct. 25. The case, started in February 2018, centered around...

GID Achieves Positive Results for Phase IIb Trial of Cell Therapy for Knee OA

The GID Group, a cellular medicine company based in Colorado, is moving toward FDA market approval for its SVF-2 treatment for osteoarthritis. The latest clinical trial results were posted on Aug. ...

Perimetry Device Market to Generate $258 Million in 2019

Perimetry devices are primarily used by eye care professionals as a tool to help diagnose and stage glaucoma patients. The glaucoma diagnostic market as a whole is worth $388 million; perimetry dev...

STAAR Surgical Posts Q3-2019 Revenue of $39.1 Million, a 23 Percent Increase

STAAR Surgical reported Oct. 30 that its net sales for Q3-2019 were $39.1 million, up 23 percent from Q3-2018. Net sales for its implantable collamer lens (ICL) increased 28 percent to $33.8 millio...

Regeneron’s Net Sales of Eylea in the US Increase 16 Percent in Q3-2019

Regeneron’s US net sales of Eylea in Q3-2019 totaled $1.19 billion, a 16 percent increase over Q3-2018, the Tarrytown, New York, company announced Nov. 5. Bayer, which licenses Eylea outside the US...

LENSAR Reports Q3-2019 Revenue of $8.1 Million, a 22 Percent Increase

LENSAR recorded Q3-2019 revenue of $8.1 million from its LENSAR Laser System, representing a 22 percent increase over Q3-2018, parent PDL BioPharma reported Nov. 6. PDL said the majority of the inc...

Glaukos’ Q3-2019 Net Sales Total $58.5 Million, a 33 Percent Increase

Glaukos’ net sales in Q3-2019 totaled $58.5 million, a 33 percent increase over net sales of $43.9 million in the third quarter of 2018, the San Clemente, California, company announced Nov. 6. Glau...

Avedro Reports Q3-2019 Net Sales of $11 Million, a 38 Percent Increase

Avedro’s net sales grew to $11 million in Q3-2019, a 38 percent increase over Q3-2018 net sales of $8 million, the Waltham, Massachusetts, company announced Nov. 6. US revenue rose $3.6 million for...

Allergan Records Q3-2019 Net Revenue of $4.05 Billion, a 3.6 Percent Increase

Allergan reported Nov. 5 that its Q3-2019 net revenue totaled $4.05 billion, a 3.6 percent increase over Q3-2018. In the US, Restasis’ net revenue was $286.8 million, a decrease of 3.8 percent, whi...

Ophthalmologist Spencer P. Thornton Dies at Age 90

Trump to Nominate Stephen Hahn, Cancer Researcher, to Head US FDA

President Donald Trump said Nov. 1 that he intended to nominate Stephen Hahn, MD, a top executive at the University of Texas MD Anderson Cancer Center, to be the next commissioner of the US FDA, ac...

AGTC Plans Stargardt Disease as its Second Preclinical Ophthalmology Program

Applied Genetic Technologies Corporation (AGTC), with facilities in Florida and Massachusetts, announced Nov. 5 that it had identified Stargardt disease as the second ophthalmology program in its p...

EyePoint’s Dexycu and Yutiq Added to Department of Veteran Affairs Federal Supply Schedule

EyePoint Pharmaceuticals, of Watertown, Massachusetts, announced Nov. 4 that it had signed an interim agreement with the US Department of Veteran Affairs for Dexycu and Yutiq to be included on the ...

Pixium Vision Reaches Financing Deal for Advancing its Prima System

French company Pixium Vision announced Nov. 6 that it had concluded a financing agreement with a US-based health care investor, the European Select Growth Opportunities Fund, for the development of...

Q BioMed Announces $7.5 Million Grant Benefiting its Preclinical Pipeline

Q BioMed Inc., of New York, announced Nov. 5 that its technology partner, Mannin, had received a $7.5 million grant from the German state of Saxony. Mannin is a research-stage biotechnology company...

Biogen Licenses Ophthalmic Biosimilar Candidates from Samsung Bioepis

Samsung Bioepis, of Incheon, South Korea, announced Nov. 6 that Biogen had agreed to a commercial license for two biosimilar candidates under development by Samsung Bioepis—SB11 (ranibizumab) and S...

Orthopedic US FDA 510(k) Clearances

During the past month, 52 orthopedic medical devices have received FDA 510(k) clearance. Eighteen of the devices are spine implants. Eight of these are for spine fixation, including three plates an...

Intraarticular Cartilage Regeneration

Results from two recent clinical studies demonstrated promising methods to stimulate regrowth of damaged cartilage tissue. If intraarticular cartilage can be regenerated, more osteoarthritis cases ...

Surgeons Report on ADR Preferences and Patient Selection Criteria

Market Scope surveys spine, knee, hip, and shoulder surgeons every quarter about procedure volumes, preferred treatments, adoption of new technology, surgical techniques, and plans. Our Q3-2019 spi...

Orthopedic Deals Surpass $42 Million in 30 Days

Between Sept. 20 and Oct. 20, five important orthopedic deals took place: one acquisition, one manufacturing agreement, one round of Series A financing, one equity announcement, and a grant. Not in...

Positive US Payer Decisions to Drive Artificial Disc Replacement Market

Currently, 11 artificial disc replacement (ADR) devices are approved by the FDA. Only three of these are approved for use in the lumbar spine, and only two are currently marketed (ActivL and Prodis...

83 Countries Represented at EUROSPINE 2019

The 2019 EUROSPINE congress was held Oct. 16-18 at the Messukeskus Expo and Convention Centre in Helsinki, Finland. Over 2 thousand health care professionals attended, representing 83 countries. Me...

Manufacturers Paid $568 Million to US Orthopedic Doctors and Neurosurgeons in 2018

US orthopedic surgeons and neurosurgeons received a total of $2.7 billion in payments from drug and device manufacturers from 2014 through 2018, according to Market Scope’s analysis of the CMS Open...

Garwood Medical’s BioPrax Receives FDA Breakthrough Device Designation

Garwood Medical Devices, a medical equipment manufacturer in New York, issued a press release on Oct. 23, stating that its BioPrax device received breakthrough device designation from the FDA. BioP...

Smith & Nephew CEO Steps Down

On Oct. 21., Smith & Nephew announced that its CEO, Namal Nawana, would leave his position by mutual agreement on Oct. 31. Roland Diggelmann assumed the role on Nov. 1, and Nawana will advise him u...

hipEOS 3.0 and HIP Smart Navigation System Used in Conjunction at HSS

EOS imaging said Oct. 21 that its hipEOS 3.0 surgical planning software was paired with Intellijoint Surgical’s HIP navigation system at the Hospital for Special Surgery (HSS) in New York. hipEOS 3...

Synaptive Medical Brings Robotic Microscope to Spine Surgery Market

Canada-based Synaptic Medical announced Oct. 17 that it is entering the spine surgical market with its robotically controlled digital microscope, Modus V. The Modus V moves based on the position of...

Oyster Point Pharma Raises $92M in IPO for Dry Eye Nasal Spray Candidate

Oyster Point Pharma raised $92 million in gross proceeds in its initial public offering Oct. 31. President and CEO Jeffrey Nau, PhD, and several Oyster Point employees rang the Nasdaq opening bell ...

J&J Vision Shuts Down Sightbox Contact Lens Service

Amarantus Licenses MANF Retinal Candidate, Other Assets to Emerald Organic Growth

Alimera Sciences Announces Equity Purchase Deal for up to $20 Million with Lincoln Park Capital

Alimera Sciences, of Alpharetta, Georgia, has entered into a common stock purchase agreement of up to $20 million with Lincoln Park Capital Fund LLC, a Chicago-based institutional investor, the com...

Luneau Technology Acquires Next Sight to Enter Telehealth Market

Luneau Technology, of France, announced Oct. 11 that it had acquired Next Sight, an Italian company specializing in retinal screening and telehealth. Terms of the deal were not disclosed. Luneau’s ...

Allergan Shareholders Approve Proposed Acquisition by AbbVie

Allergan announced Oct. 14 that its shareholders had voted to approve the previously announced proposed acquisition of Allergan by AbbVie. More than 99 percent of the votes cast at both a special c...

Avellino Labs Receives US Certification for AvaGen Diagnostic Test for Keratoconus and Corneal Dystrophies

Avellino Labs announced Oct. 14 that the company had received Clinical Laboratory Improvement Amendments (CLIA) certification for its AvaGen product, the first genetic test for determining risk of ...

Wills Eye Top Ophthalmologist Julia A. Haller Elected to National Academy of Medicine

Wills Eye Hospital announced Oct. 23 that its ophthalmologist-in-chief, Julia A. Haller, MD, was elected to the US National Academy of Medicine (NAM). The honor is considered one of the highest in ...

Galimedix Appoints Alexander Gebauer, MD, PhD, as Executive Chairman

Galimedix Therapeutics has appointed Alexander Gebauer, MD, PhD, as executive chairman of the board, the company announced Oct. 21. Gebauer succeeds founder Andrew Pearlman, PhD, who will remain on...

Notal Vision Announces Appointment of Kester Nahen as Chief Executive Officer

Notal Vision has appointed Kester Nahen, PhD, as chief executive officer, the company announced Oct. 23. Nahen joined the company as chief commercial officer in August. Prior to joining Notal Visio...

Spark Therapeutics Wins Prix Galien USA Award for Luxturna as Best Biotechnology Product

Spark Therapeutics, of Philadelphia, announced Oct. 25 that it had been awarded the prestigious 2019 Prix Galien USA Award for Best Biotechnology Product for its retinal gene therapy Luxturna. The ...

NovaBay to Distribute NuLids for Dry Eye in Certain US Markets

NovaBay Pharmaceuticals has entered into an exclusive 90-day agreement with NuSight Medical to distribute the NuLids System for treatment of blepharitis and dry eye in six of NovaBay’s top-performi...

TLC Announces Completion of $27.3 Million Financing

TLC, of Taipei, Taiwan, said Oct. 24 that it had closed a cash capital offering of ordinary or common shares. The offering consisted of 10.2 million new common shares issued at a price of NT $82 (U...

LimaCorporate to Distribute Dedienne Santé’s Symbol Acetabular Cups

LimaCorporate announced Oct. 15 that is signed a distribution agreement with Dedienne Santé for Dedienne’s dual-mobility acetabular cup portfolio, Symbol. Under the terms, LimaCorporate will distri...

StemSpine Treatment Scheduled to Launch in US

Creative Medical Technology Holdings said Oct. 17 that StemSpine achieved clinical commercialization and will launch soon in the US. Creative Medical focuses on stem cell treatments for orthopedics...

CMR Surgical Sells First Versius Surgical Robotic System and Launches Clinical Registry

CMR Surgical announced Oct. 16 that Galaxy Care Hospital in India became the first to acquire CMR’s Versius Surgical Robotic System. Galaxy Care Hospital is a large, well-known laparoscopic surgery...

Arthrosurface Nonspherical Shoulder Replacement Achieves Positive Outcomes for Concentric and Nonconcentric Glenoid Cases

Arthrosurface announced publication of its recent study results in the October issue of JESE Open Access. Thirty-one shoulder replacements in 29 patients were compared using the Penn Shoulder Score...

Shukla Using Markforged Metal X Printer to Make Prototype Surgical Tools

Markforged announced Oct. 7 that Shukla Medical, a surgical tool manufacturer, is using Markforged’s Metal X system to print prototype surgical tools. This allows Shukla to quickly print stainless ...

Want to Read Locked Articles?

Register A Corporate Account

A corporate accounts gives you access to licensed reports and subscriptions, the latest news, and a personalized dashboard.